Elsevier

Annals of Oncology

Volume 31, Supplement 4, September 2020, Page S1177
Annals of Oncology

NSCLC, early stage
LBA1 Osimertinib adjuvant therapy in patients (pts) with resected EGFR mutated (EGFRm) NSCLC (ADAURA): Central nervous system (CNS) disease recurrence

https://doi.org/10.1016/j.annonc.2020.08.2279Get rights and content
Under an Elsevier user license
open archive

Cited by (0)